Esteban Martínez Selected Research

Esteban Martínez Research Topics

Disease

19	HIV Infections (HIV Infection) 02/2023 - 03/2002
19	Lipodystrophy 01/2015 - 12/2002
8	Insulin Resistance 01/2023 - 10/2003
8	Infections 12/2022 - 12/2002
8	Acquired Immunodeficiency Syndrome (AIDS) 03/2019 - 09/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 02/2009
5	Inflammation (Inflammations) 01/2023 - 03/2008
4	Hepatitis B 11/2023 - 11/2004
4	Hypertension (High Blood Pressure) 10/2023 - 01/2010
4	COVID-19 12/2022 - 10/2020
4	Fibrosis (Cirrhosis) 04/2022 - 01/2005
4	Hyperlactatemia 12/2009 - 11/2003
3	Heart Failure 01/2023 - 07/2002
3	Thrombophilia 01/2023 - 01/2010
3	Weight Gain 01/2023 - 12/2021
3	Dyslipidemias (Dyslipidemia) 09/2014 - 02/2006
3	Coinfection 05/2014 - 01/2005
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2011 - 02/2006
2	Osteoporosis 10/2021 - 05/2018
2	Virus Diseases (Viral Diseases) 01/2015 - 01/2011
2	Chronic Renal Insufficiency 11/2014 - 01/2014
2	Necrosis 11/2014 - 09/2009
2	Pancreatitis 01/2013 - 07/2004
2	Hepatitis C 10/2012 - 11/2004
2	Diabetes Mellitus 01/2012 - 01/2010
2	Encephalitis (Encephalitis, Rasmussen) 03/2011 - 07/2006
2	Lactic Acidosis 01/2005 - 03/2002
1	Cognitive Dysfunction 04/2024
1	Leukocytosis (Pleocytosis) 04/2024
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 02/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2022
1	Opportunistic Infections (Opportunistic Infection) 04/2016
1	Human Influenza (Influenza) 02/2015
1	Lipomatosis 01/2015
1	Obesity 01/2015
1	Glycosuria 11/2014
1	Atrophy 08/2014

Drug/Important Bio-Agent (IBA)

9	Protease Inhibitors (Protease Inhibitor)IBA 10/2023 - 09/2003
8	Mitochondrial DNA (mtDNA)IBA 01/2019 - 08/2003
7	Tenofovir (Viread)FDA Link 11/2023 - 07/2004
7	LipidsIBA 01/2023 - 09/2003
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 10/2003
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2010
5	CholesterolIBA 01/2022 - 04/2004
4	dolutegravirIBA 10/2023 - 03/2015
4	Antiviral Agents (Antivirals)IBA 12/2022 - 01/2011
4	RNA (Ribonucleic Acid)IBA 10/2021 - 09/2003
3	AdiponectinIBA 01/2023 - 01/2010
3	Emtricitabine (Emtriva)FDA Link 12/2022 - 01/2010
3	HDL CholesterolIBA 01/2022 - 01/2010
3	LDL CholesterolIBA 01/2022 - 01/2010
3	Reverse Transcriptase InhibitorsIBA 10/2020 - 03/2002
3	abacavir (Ziagen)FDA Link 10/2020 - 09/2003
3	NucleosidesIBA 01/2011 - 03/2002
2	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2008
2	Antihypertensive Agents (Antihypertensives)IBA 10/2023 - 01/2023
2	Integrase InhibitorsIBA 10/2023 - 10/2022
2	RacivirIBA 12/2022 - 10/2020
2	HDL LipoproteinsIBA 01/2022 - 01/2019
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	Lamivudine (Epivir)FDA Link 10/2020 - 01/2011
2	Rilpivirine (TMC-278)IBA 01/2020 - 06/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 11/2014 - 09/2009
2	InterleukinsIBA 05/2014 - 01/2010
2	Stavudine (Zerit)FDA LinkGeneric 01/2013 - 01/2005
2	ThymidineIBA 01/2011 - 07/2009
2	C-Reactive ProteinIBA 01/2010 - 09/2009
2	efavirenz (Sustiva)FDA Link 08/2008 - 09/2003
1	Methamphetamine (Desoxyn)FDA LinkGeneric 04/2024
1	Cocaine (Cocaine HCl)IBA 04/2024
1	AntibodiesIBA 11/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Viral RNAIBA 12/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2022
1	Lipopolysaccharide ReceptorsIBA 12/2021
1	tenofovir alafenamideIBA 10/2020
1	pyrimidineIBA 01/2020
1	Darunavir (Prezista)FDA Link 01/2020
1	Nucleic AcidsIBA 02/2015
1	CytokinesIBA 01/2015
1	SmokeIBA 01/2015
1	Phosphates (Orthophosphate)IBA 11/2014
1	Ezetimibe (Zetia)FDA Link 09/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2014
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 05/2014
1	Ritonavir (Norvir)FDA Link 05/2014
1	oxidized low density lipoproteinIBA 02/2013
1	stavudine triphosphateIBA 01/2013
1	Thymidylate SynthaseIBA 01/2013

Therapy/Procedure

26	Therapeutics 04/2022 - 03/2002
19	Highly Active Antiretroviral Therapy (HAART) 01/2015 - 07/2002
4	Art Therapy 10/2020 - 02/2013
2	Aftercare (After-Treatment) 08/2014 - 01/2005
1	Retention in Care 02/2023
1	Continuity of Patient Care 02/2023
1	Condoms (Condom) 02/2023
1	Palliative Care (Palliative Therapy) 04/2016